News & Updates
Filter by Specialty:
Low carbohydrate diet lowers risk of MetS, remnant cholesterol in prostate cancer
A low carbohydrate diet (LCD) may substantially reduce the risk of metabolic syndrome (MetS) and remnant cholesterol in patients with prostate cancer, a recent study has shown.
Low carbohydrate diet lowers risk of MetS, remnant cholesterol in prostate cancer
16 Nov 2021Dose-reduced ARPI leads to inferior survival in CRPC patients
Reduced-dose treatment with androgen receptor pathway inhibitors (ARPI) lead to poorer oncological outcomes relative to full-dose regimens in castration-resistant prostate cancer (CRPC), a recent study has found.
Dose-reduced ARPI leads to inferior survival in CRPC patients
09 Nov 2021Chlormadinone prolongs active surveillance, maintains QoL in men with prostate cancer
Use of the oral antiandrogen chlormadinone at a low dose led to improvements in persistence rate of active surveillance (AS), PSA* and testosterone levels and prostate volume, and quality of life (QoL) in men with low-risk prostate cancer (PCa), the PROSAS study has shown.
Chlormadinone prolongs active surveillance, maintains QoL in men with prostate cancer
05 Nov 2021RS-RARP confers better continence outcomes than conventional RARP
In prostate cancer patients, retzius-sparing robotic-assisted radical prostatectomy (RS-RARP) yields better continence outcomes compared with conventional RARP, a recent study has found.
RS-RARP confers better continence outcomes than conventional RARP
03 Nov 2021Mendelian analysis links coffee drinking to lower kidney stone risk
Genetic data provide evidence that drinking coffee or caffeine intake in high amounts may cause a reduction in the risk of kidney stones, as shown in a study.